Bavarian Nordic

Report Publication Announcement • Sep 15, 2010

Bavarian Nordic issues Financial Calendar for 2011

Bavarian Nordic issues Financial Calendar for 2011

Kvistgård, Denmark, September 15, 2010 - Bavarian Nordic A/S (OMX: BAVA)
announced today its financial calendar for the year 2011.

10 March 2011 Annual accounts

26 April 2011 Annual General Meeting

18 May 2011 First quarterly report (Q1) for the three-month period ended
31 March 2011

31 August 2011 Half-year report (Q2) for the six-month period ended 30 June
2011

16 November 2011 Third quarterly report (Q3) for the nine-month period ended 30
September 2011

Going forward, Bavarian Nordic introduces silent periods in relation to its
quarterly results. Thus, in a period of 2 weeks before planned publication of
quarterly reports, the company will not comment on developments or financial
issues and expectations. The dates for silent periods will be published on the
company's website: www.bavarian-nordic.com/investor

Asger Aamund
Chairman of the Board

Contact
Anders Hedegaard, President & CEO. Phone +45 23 20 30 64

About Bavarian Nordic
Bavarian Nordic A/S is a leading industrial biotechnology company developing and
producing novel vaccines for the treatment and prevention of life-threatening
diseases with a large unmet medical need. The company's pipeline is focused in
the three areas; cancer, biodefence and infectious diseases, and includes seven
development programmes. Two programmes are under preparation for Phase III:
PROSTVAC(TM), a therapeutic vaccine for advanced prostate cancer is being
developed under a collaboration agreement with the National Cancer Institute,
and IMVAMUNE®, a third-generation smallpox vaccine is being developed under a
contract with the US government.

Bavarian Nordic is listed on NASDAQ OMX Copenhagen under the symbol BAVA.

For more information please visit www.bavarian-nordic.com

Forward-looking statements
This announcement includes "forward-looking statements" that involve risks,
uncertainties and other factors, many of which are outside of our control that
could cause actual results to differ materially from the results discussed in
the forward-looking statements. Forward-looking statements include statements
concerning our plans, objectives, goals, future events, performance and/or other
information that is not historical information. We undertake no obligation to
publicly update or revise forward-looking statements to reflect subsequent
events or circumstances after the date made, except as required by law.

[HUG#1444344]

Attachments:

• 201030uk

  ---

  This content was distributed through

  

  - connecting communication professionals with their target audience. Visit us here.